Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_ex31-1.htm |
| EX-10.28 - EXHIBIT 10.28 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_ex10-28.htm |
| EX-4.1 - EXHIBIT 4.1 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_ex4-1.htm |
| EX-3.1 - EXHIBIT 3.1 - CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | tm205316d1_ex3-1.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Creative Medical Technology Holdings, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned principal executive officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: April 3, 2020
| /s/ Timothy Warbington | |
| Timothy Warbington, Chief Executive Officer | |
| (Principal Executive Officer) |